High expression level of RELL2 predicted a poor survival outcome in ACC, CESC, GBM, KICH, KIRC, PCPG, THCA, and UCS and indicated a good survival in PAAD (P = 0.001) (Figure 3(b)). This evidence concerns the gene RELL2 and glioblastoma.